Two recent studies from researchers at Washington University School of Medicine in St. Louis have identified a promising way ...
Since the exact cause is not known, it may not be easy to prevent breast cancer. However, reducing the risks of breast cancer ...
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...